Risk of Injuries Up Around Period of Cancer Diagnosis

Share this content:
Risk of Injuries Up Around Period of Cancer Diagnosis
Risk of Injuries Up Around Period of Cancer Diagnosis

FRIDAY, Sept. 2, 2016 (HealthDay News) -- Patients with cancer have increased risks of iatrogenic and non-iatrogenic injuries shortly before and after cancer diagnosis, according to a study published online Aug. 31 in The BMJ.

Qing Shen, from the Karolinska Institutet in Stockholm, and colleagues examined the risks of iatrogenic and non-iatrogenic injuries before and after cancer diagnosis using data from Swedish national population and health registers. Data were included for 720,901 patients with a cancer diagnosis from 1991 to 2009.

The researchers identified 7,306 iatrogenic and 8,331 non-iatrogenic injuries during the diagnostic period (incidence rates, 0.60 and 0.69 per 1,000 person-months, respectively). Compared with the pre-diagnostic period, during the diagnostic period the incidence rate ratio for iatrogenic injuries was 7.0. The increase in risk started two weeks prior to diagnosis of cancer and peaked during the two weeks following diagnosis (48.6). The incidence rate ratio was 1.9 during the diagnostic period versus the pre-diagnostic period for non-iatrogenic injuries. The risk began to increase four weeks pre-diagnosis and peaked during the two weeks preceding diagnosis (incidence rate ratio, 5.3). For all common cancers there were increased risks for both types of injury during the diagnostic period, with the smallest risk increase for non-melanoma skin cancer.

"These findings shed further light on the total burden of medical complications and call for prevention of intentional and unintentional injuries during the diagnostic process of cancer," the authors write.

Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »